US › Healthcare

Perspective Therapeutics Inc. (CATX)

US · Healthcare · Medical Devices

$2.17-7.26%

Last close · 2026-10-16

Latest quarter · ended 2026-06-30

Revenue

$81,000

Revenue YoY

-72.1%

Net profit

$-26.8M

EPS

$-0.22

EPS estimate

$-0.27

Net margin

-33,069.1%

EPS came in at -0.22 against a street estimate of -0.27 — a beat of 18.5%.

Key statistics

Market cap

$259.1M

Forward P/E

25.7

P/B

0.92

Book value

$2.84

EPS (TTM)

$-1.20

52-week high

$6.16

52-week low

$1.96

50-day MA

$2.93

200-day MA

$3.60

Beta

1.85

Analyst view

Analysts rate Perspective Therapeutics Inc. a strong buy (13 buy, 1 hold, 0 sell out of 14) with an average price target of $12.29.

Shareholding

Insiders

8.23%

Institutions

86.03%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Perspective Therapeutics Inc. — free to start.

Open in the app Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Gilead Sciences Inc Abbott Laboratories Novo Nordisk A/S

Data updated 2026-10-18.